TickerFacts.

RxSight, Inc. (RXST): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$3.27M
Year ended 2025-12-31
$3.54M
Trailing 12 months to 2026-06-30
-5.6%
3-year compound annual growth
-3.3%
5-year compound annual growth
$4.08M2020-12-31: $3.85M2021-12-31: $3.98M2022-12-31: $3.88M2023-12-31: $4.08M2024-12-31: $3.58M2025-12-31: $3.27M$3.27M
2020-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$3.27M-8.6%2026-02-25, From 2025-01-01
2024-12-31$3.58M-12.3%2026-02-25, From 2024-01-01
2023-12-31$4.08M+5.0%2026-02-25, From 2023-01-01
2022-12-31$3.88M-2.3%2025-02-25, From 2022-01-01
2021-12-31$3.98M+3.2%2023-03-06, From 2021-01-01
2020-12-31$3.85Mn/a2022-03-08, From 2020-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
RxSight, Inc. (RXST)2025-12-31$3.27M-8.6%
Warby Parker Inc. (WRBY)2025-12-31$50.28M+9.6%
National Vision Holdings, Inc. (EYE)2026-01-03$91.15M-0.2%
Cooper Companies, Inc. (COO)2025-10-31$377.40M+0.6%
Bausch & Lomb Corp (BLCO)2025-12-31$421.00M-3.4%
Innovative Eyewear Inc (LUCYW)2025-12-31$66.8K-39.0%

Compare RXST, WRBY, EYE, COO side by side · Screen every company in Ophthalmic Goods ↗